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In areas where melioidosis is endemic, stress on the
healthcare system is substantial. Because clinical manifes-
tations are protean, the illness is difficult to diagnose, and
cutaneous  Burkholderia pseudomallei infections can
progress to necrotizing fasciitis. While it is an uncommon
complication of cutaneous melioidosis, necrotizing fasciitis
is potentially fatal and requires aggressive management,
including early diagnosis, appropriate antibiotics selection,
and operative débridement. 
M
elioidosis is a disease caused by a gram-negative
bacterium, Burkholderia pseudomallei. Endemic to
Southeast Asia, Taiwan, China, Central and South
America, and northern Australia, sporadic infections occur
throughout the world, usually in travelers to the disease-
endemic areas (1–3). Humans are usually infected by soil
contamination of puncture wounds. The respiratory tract is
the most common site of infection (3). Cutaneous melioi-
dosis with necrotizing fasciitis is rare: we found no reports
of cutaneous melioidosis with necrotizing fasciitis and
only one previous report of melioidosis with necrotizing
fasciitis, which complicated postoperative drainage of a
parotid abscess (4).
The Study
A 61-year-old Chinese man with a history of psoriasis
and alcoholic liver cirrhosis sought treatment for left ankle
swelling, erythema, and tenderness. He worked as a dish-
washer in a restaurant and could not recall any antecedent
trauma to the affected limb. He was febrile on admission
and was empirically treated with intravenous penicillin
and cloxacillin for cellulitis. Despite antimicrobial drug
therapy, his lower limb infection progressed with forma-
tion of cutaneous blisters. A decision for wound débride-
ment was made. During surgery, grayish necrotic fascia,
extensive subcutaneous tissue necrosis, loss of resistance
of the normally adherent superficial fascia to blunt dissec-
tion, and foul-smelling “dishwater” pus were noted. A
diagnosis of necrotizing fasciitis was made. 
The tissue specimen was spread onto blood agar plate
(trypticase soy agar supplemented with 5% sheep blood,
BBL [Becton, Dickinson and Company, Franklin Lakes,
NJ]) and Ashdown’s media, a selective media for B.
pseudomallei. Characteristic colonial morphologic find-
ings of B. pseudomallei were noted on blood agar and
Ashdown’s media. The organism’s identity was confirmed
with biochemical tests (positive oxidase reaction, simmons
citrate) and microscopic morphologic findings. (The auto-
mated blood culture system used was the BACTEC
Fluorescent Series blood culture system [Becton,
Dickinson and Company].) Tissue (taken during surgery)
and blood cultures grew B. pseudomallei susceptible to
ceftazidime, amoxicillin/clavulanic acid, imipenem, chlo-
ramphenicol, and cotrimoxazole but resistant to ampicillin,
amikacin, and gentamicin. Results of melioidosis serolog-
ic testing were also positive. The patient’s chest
roentgenogram was normal. A computed tomography scan
of his abdomen and pelvis showed splenic abscesses, but
no prostatic abscess was noted. A digital rectal examina-
tion demonstrated an enlarged prostate that was nontender.
The patient underwent two further operations for wound
débridement and split thickness skin grafting. He was
treated with ceftazidime and doxycycline; when his fever
persisted, his treatment was converted to intravenous
imipenem. He responded well and was discharged after he
completed a 4-week course of imipenem. On discharge, no
oral antimicrobial drugs were dispensed.
One month later, the man was readmitted with fever
associated with scrotal swelling and pain. On examination,
a firm, tender right prostatic nodule was noted. A transrec-
tal ultrasound showed abscesses in both prostatic lobes.
The aspirate from the prostatic abscesses and blood cul-
tures grew B. pseudomallei with antimicrobial drug sus-
ceptibilities identical to the organism cultured from his ini-
tial admission. A6-week course of intravenous ceftazidime
was given. He also underwent transurethral resection of
the prostate; the histologic results indicated benign prosta-
tic hyperplasia with acute on chronic inflammation. On
discharge, he was prescribed oral amoxicillin-clavulanate
(for 4 weeks) and doxycycline (for 1 year).
Seventeen months after cessation of oral antibiotics, he
reappeared with a left temporal scalp abscess and fever. No
organism was isolated from the scalp pus culture, but the
blood culture again grew B. pseudomallei with identical
antimicrobial drug susceptibilities. He was given 4 weeks
of ceftazidime followed by amoxicillin-clavulanate (for 4
weeks) and doxycycline (long-term). After 8 months on
oral doxycycline, the patient was symptom-free. 
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Conclusions
This patient history is representative of the protean clin-
ical features of melioidosis. The disease has been called
the great mimicker, with a wide range of clinical syn-
dromes including pneumonia, visceral abscesses, soft tis-
sue infections, septic arthritis, and septicemia (1,3,5). Lim
et al. previously reported a case of melioidosis with a
parotid abscess that was drained and subsequently pro-
gressed to necrotizing fasciitis (4). Although not previous-
ly reported, necrotizing fasciitis can be the initial sign of
melioidosis. While cutaneous infections by B. pseudoma-
llei are usually indolent soft tissue infections manifesting
as cellulitis or abscesses (1–3,6), these soft tissue infec-
tions can progress to necrotizing fasciitis in melioidosis.
Melioidosis can remain latent for prolonged periods
and reactivate with severe sepsis years after the initial
infection (1,7). Melioidosis is characterized by relapses or
recrudescence, especially in immunocompromised
patients (1,7,8). For this patient, the first relapse occurred
1 month after the first hospital discharge. Another relapse
occurred 17 months after cessation of oral maintenance
antimicrobial drug therapy. 
For patients with a known history of melioidosis,
antimicrobial agents for B. pseudomallei should be used.
B. pseudomallei are frequently intrinsically resistant to
many antimicrobial agents, including aminoglycosides and
first- or second-generation cephalosporins. Current recom-
mended therapy of severe melioidosis includes intra-
venous ceftazidime or imipenem for 10 days to 4 weeks,
followed by maintenance oral antimicrobial agents (amox-
icillin-clavulanate or a combination of trimethoprim-sul-
famethoxazole and doxycycline) for 10 to 18 weeks (9).
In the context of soft tissue infections, patients with a
history of melioidosis developing cutaneous septic foci
should be treated promptly and aggressively with antibi-
otics against B. pseudomallei in addition to the common
organisms responsible for these infections such as
Staphylococci aureus and streptococcal species. In this set-
ting, an intravenous regime consisting of crystalline peni-
cillin and cloxacillin may not be the appropriate initial
antimicrobial drug regime (3). Awareness that soft tissue
infection can progress to necrotizing fasciitis, a life- and
limb-threatening condition, is important, and a high index
of suspicion should be maintained. When necrotizing
fasciitis is suspected, magnetic resonance imaging of the
affected area should be performed to ensure early diagno-
sis, and aggressive débridement of all nonviable tissue
should follow for an improved outcome (10). 
Melioidosis is a major problem and a rampant disease
in rural parts of Central and South America, North
Australia, and Southeast Asia. In northeast Thailand, it is
responsible for 20% to 40% of deaths from community-
acquired septicemia (11). Its true incidence is probably
underestimated due to under detection and limited avail-
ability of culture facilities (12). Awareness of the spectrum
of soft tissue infections caused by B. pseudomallei, includ-
ing the distinct possibility of necrotizing fasciitis at the
extreme of the spectrum, is important. The successful man-
agement of necrotizing fasciitis requires appropriate
antimicrobial drug selection and aggressive operative
débridement. 
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